arrow
M

Marı́a Pérez-Vázquez

instituto de salud carlos iii
H指数:43
被引数:9,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multivalent OMV vaccine induces broad protection against major Klebsiella pneumoniae disease-causing serotypes

多价OMV疫苗对主要肺炎克雷伯菌致病血清型产生广谱保护

2026-11-020
OAAI
Depolymerase architecture and antibiofilm activity in two phages targeting ESBL-producing Escherichia coli

解聚酶结构和抗生物膜活性在靶向产超广谱β-内酰胺酶大肠杆菌的两个噬菌体中的作用

2026-10-290
OAAI
Carbapenemase-producing Acinetobacter baumannii from Spanish hospitals, 2016-2020: Interregional spread of ST2PAS isolates co-harbouring blaOXA-23, blaOXA-66 and armA genes.

西班牙医院中产碳青霉烯酶的<em>鲍曼不动杆菌</em>(2016-2020年):携带<em>bla</em><sub>OXA-23</sub>、<em>bla</em><sub>OXA-66</sub>和<em>arm</em><sub>A</sub>基因的ST2<sup>PAS</sup>菌株的区域间传播

2026-08-170
OAAI
Correction: KpFhaB/FhaC is a virulence-associated TPS system of the globally-disseminated Klebsiella pneumoniae ST15 high-risk clone

更正:KpFhaB/FhaC是全球流行的肺炎克雷伯菌ST15高风险克隆株的毒力相关TPS系统

2026-08-140
OA
Multidrug-resistant gram-negative bacteria in Spanish ICU patients: clinical and microbiological characterization (MURAN-UCI Project)

西班牙ICU患者中多重耐药革兰氏阴性菌的临床和微生物学特征(MURAN-UCI项目)

2025-12-010
PRE
Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of β-lactams and the novel β-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenemase-producing Enterobacterales

评估新出现的产生双碳青霉烯酶的肠杆菌对头孢地罗以及 β-内酰胺和新型 β-内酰胺酶抑制剂阿维巴坦,他尼伯巴坦,齐德巴坦,纳卡巴坦,xerubbactam和ANT3310的组合的抗性活性和机制

2024-11-062
PRE
Dissemination of extensively drug-resistant NDMproducing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023

2022 3月至2023 3月在欧洲传播与从乌克兰转移的患者有关的广泛耐药的ndm生产Providencia stuartii

2024-06-063
OAAI
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

西班牙产生碳青霉烯酶的肺炎克雷伯菌和大肠杆菌引起的社区,医疗保健相关和医院定植和感染的流行病学和临床特征

2024-05-041
OAAI
Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak
MSPHERE
IF3.1
2024-03-2617
OAAI
CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3 (vol 13, 918362, 2022)

来自西班牙所有省份的产碳青霉烯酶肺炎克雷伯菌和大肠杆菌的CARB-ES-19多中心研究揭示了高风险克隆的区域间传播,如ST307/OXA-48和ST512/KPC-3 (第13卷,918362,2022)

2023-11-280
OAAI
Phenotypic and molecular characterization of IMP-producing Enterobacterales in Spain: predominance of IMP-8 in Klebsiella pneumoniae and IMP-22 in Enterobacter roggenkampii (Vol 13, 1000787, 2022)
2023-11-240
OAAI
An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004-2020)
2023-09-265
OAAI
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
2023-09-0136
OAAI